Dr. David Graham’s testimony for federal Vioxx trials “goes beyond anything he has said previously and shouldn’t be heard by jurors,” said Merck’s attorneys. Graham alleged that the drug maker dragged its feet about adding a warning label and that Vioxx should not have even been approved when it was. A hearing is scheduled for later this week to decide what part of his depositions will be allowed in a lawsuit filed by a retired FBI agent who took Vioxx before suffering a heart attack.
Merck Seeks to Block FDA Whistle Blower's Testimony
Dr. David Graham’s testimony for federal Vioxx trials “goes beyond anything he has said previously and shouldn’t be heard by jurors,” said Merck’s attorneys. Graham alleged that the drug maker dragged its feet about adding a warning label and that Vioxx should not have even been approved when it was
Legal Examiner Staffer
Legal Examiner staff writers come from diverse journalism and communications backgrounds. They contribute news and insights to inform readers on legal issues, public safety, consumer protection, and other national topics.
All articles
Tags:
Legal